NRX Pharmaceuticals Inc.(NRXP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NRXP NRX Pharmaceuticals Inc.

休市中 08-23 16:00:00 EDT

2.08

+0.04

+1.96%

盘后2.15

+0.07+3.37%

18:42 EDT

最高2.14	最低2.05	成交量3.80万
今开2.11	昨收2.04	日振幅4.41%
总市值2,252万	流通市值1,660万	总股本1,083万
成交额7.93万	换手率0.48%	流通股本797.84万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NRXP","market":"US","secType":"STK","nameCN":"NRX Pharmaceuticals Inc.","latestPrice":2.08,"timestamp":1724443200000,"preClose":2.04,"halted":0,"volume":37965,"hourTrading":{"tag":"盘后","latestPrice":2.15,"preClose":2.08,"latestTime":"18:42 EDT","volume":694,"amount":1440.1336,"timestamp":1724452951083},"delay":0,"floatShares":7978391,"shares":10828027,"eps":-2.789961,"marketStatus":"休市中","marketStatusCode":7,"change":0.04,"latestTime":"08-23 16:00:00 EDT","open":2.11,"high":2.14,"low":2.05,"amount":79346.7550875,"amplitude":0.044118,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.789961,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"adjPreClose":2.04,"preHourTrading":{"tag":"盘前","latestPrice":2.08,"preClose":2.04,"latestTime":"09:19 EDT","volume":179,"amount":371.4109664,"timestamp":1724419140910},"postHourTrading":{"tag":"盘后","latestPrice":2.15,"preClose":2.08,"latestTime":"18:42 EDT","volume":694,"amount":1440.1336,"timestamp":1724452951083},"volumeRatio":0.557919919952057,"impliedVol":0.2496,"impliedVolPercentile":0.0278},"requestUrl":"/m/hq/s/NRXP/tweets","defaultTab":"tweets","newsList":[{"id":"2461839578","title":"Nrx Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.52%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461839578","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461839578?lang=zh_cn&edition=full","pubTime":"2024-08-21 03:53","pubTimestamp":1724183626,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日03时53分，Nrx Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.52%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821035346ab5ea796&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821035346ab5ea796&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2459401180","title":"Nrx Pharmaceuticals, Inc.盘中异动 急速下挫6.99%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459401180","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459401180?lang=zh_cn&edition=full","pubTime":"2024-08-16 02:49","pubTimestamp":1723747762,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日02时49分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速下跌6.99%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。其相关个股中，Cingulate Inc.、Nutriband Inc C/Wts 、Portage Biotech Inc.涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为10788.27%、2343.18%、653.88%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cingulate Inc.、Nutriband Inc C/Wts ，振幅分别为163.33%、162.60%、115.79%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081602492298e3514c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081602492298e3514c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2459495516","title":"NRX 制药公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459495516","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459495516?lang=zh_cn&edition=full","pubTime":"2024-08-15 12:50","pubTimestamp":1723697408,"startTime":"0","endTime":"0","summary":"   * NRX Pharmaceuticals Inc   报告，截至6月底的季度调整后每股亏损67美分，高于去年同期的每股收益1.20美元。两位分析师对该季度的平均预期是每股亏损 69 美分。华尔街预期为每股-81美分至-58美分。* NRX Pharmaceuticals Inc 公布的季度每股收益为亏损 75 美分。* 公司报告的季度亏损为 790 万美元。* NRX Pharmaceuticals Inc 的股价本季度下跌了 22.1%，今年迄今为止下跌了 58.7%。8月15日 - 预测变化   * 在过去三个月里，分析师的平均盈利预期下降了约 26.4%。华尔街对 NRX Pharmaceuticals Inc 的 12 个月目标价中位数为 31.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"NRX 制药公司公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2459095559","title":"Nrx Pharmaceuticals, Inc.盘中异动 急速下跌5.89%报1.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459095559","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459095559?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:32","pubTimestamp":1723555943,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时32分，Nrx Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.89%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132239f278ddf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132239f278ddf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2459558049","title":"Nrx Pharmaceuticals, Inc.盘中异动 临近收盘快速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459558049","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459558049?lang=zh_cn&edition=full","pubTime":"2024-08-13 03:31","pubTimestamp":1723491087,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日03时31分，Nrx Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.45%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.57%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813033127af9719bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813033127af9719bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2458156628","title":"NRX Pharmaceuticals Inc    预计每股亏损 69 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458156628","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458156628?lang=zh_cn&edition=full","pubTime":"2024-08-09 19:21","pubTimestamp":1723202483,"startTime":"0","endTime":"0","summary":"   * NRX Pharmaceuticals Inc    将于8月12日公布截至2024年6月30日的财报() 预计该公司的季度收入不会有变化。*    * LSEG分析师对NRX Pharmaceuticals Inc的平均预期是每股亏损69美分。* 华尔街对 NRX Pharmaceuticals Inc 的 12 个月目标价中位数为 31.00 美元，高于其上一次收盘价 2.07 美元。8月9日 - 本摘要于北京时间 8 月 9 日 11:20 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"NRX Pharmaceuticals Inc    预计每股亏损 69 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP"],"gpt_icon":0},{"id":"2457343168","title":"Nrx Pharmaceuticals, Inc.盘中异动 股价大涨5.89%报2.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457343168","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457343168?lang=zh_cn&edition=full","pubTime":"2024-08-08 23:12","pubTimestamp":1723129954,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日23时12分，Nrx Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.89%。截至发稿，该股报2.06美元/股，成交量4432股，换手率0.04%，振幅3.21%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为3.09%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808231234af96a1a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808231234af96a1a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2457841364","title":"Nrx Pharmaceuticals, Inc.盘中异动 股价大涨5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457841364","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457841364?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:37","pubTimestamp":1723037820,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时37分，Nrx Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.69%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072137009585f3bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072137009585f3bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2457250610","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.27%报2.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457250610","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457250610?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:08","pubTimestamp":1722953314,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日22时08分，Nrx Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.27%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.41%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806220835941fea41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806220835941fea41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2457077539","title":"Nrx Pharmaceuticals, Inc.盘中异动 股价大跌5.19%报2.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457077539","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457077539?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:43","pubTimestamp":1722865405,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时43分，Nrx Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.19%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.93%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214325af95fb22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214325af95fb22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2456452110","title":"Nrx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.68%报2.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456452110","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456452110?lang=zh_cn&edition=full","pubTime":"2024-08-02 01:52","pubTimestamp":1722534725,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日01时52分，Nrx Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.68%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802015205941fd161&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802015205941fd161&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2455134944","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455134944","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455134944?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:35","pubTimestamp":1722432923,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日21时35分，Nrx Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.12%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731213523af95232a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731213523af95232a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2455131930","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.08%报2.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455131930","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455131930?lang=zh_cn&edition=full","pubTime":"2024-07-30 21:42","pubTimestamp":1722346928,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日21时42分，Nrx Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.08%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730214208941fbf19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730214208941fbf19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2455663277","title":"Nrx Pharmaceuticals, Inc.盘中异动 股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455663277","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455663277?lang=zh_cn&edition=full","pubTime":"2024-07-29 21:35","pubTimestamp":1722260132,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日21时35分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.39%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729213533af94a20c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729213533af94a20c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2454328890","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘大幅上涨6.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454328890","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454328890?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:31","pubTimestamp":1722000700,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时31分，Nrx Pharmaceuticals, Inc.股票出现异动，股价大幅上涨6.84%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Windtree Therapeutics, Inc.、Nutriband Inc C/Wts 、Cel-Sci Corporation涨幅较大，Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Promis Neurosciences Inc.较为活跃，换手率分别为2739.17%、92.66%、26.52%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Cel-Sci Corporation、Cargo Therapeutics, Inc.，振幅分别为24.32%、22.31%、9.77%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213140955d9315&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213140955d9315&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2453064782","title":"Nrx Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453064782","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453064782?lang=zh_cn&edition=full","pubTime":"2024-07-24 03:24","pubTimestamp":1721762678,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日03时24分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.13%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Azitra Inc、Salarius Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc涨幅较大，Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc较为活跃，换手率分别为9902.34%、7597.25%、3731.82%，振幅较大的相关个股有Azitra Inc、Salarius Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc，振幅分别为474.07%、366.13%、155.66%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724032438af93b266&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724032438af93b266&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2441309800","title":"Ascendiant Capital：维持NRX Pharmaceuticals(NRXP.US)评级，由买入调整至买入评级, 目标价由50.","url":"https://stock-news.laohu8.com/highlight/detail?id=2441309800","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441309800?lang=zh_cn&edition=full","pubTime":"2024-06-08 23:57","pubTimestamp":1717862273,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2434899083","title":"NRX Pharmaceuticals Inc    预计每股亏损 55 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434899083","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434899083?lang=zh_cn&edition=full","pubTime":"2024-05-11 04:38","pubTimestamp":1715373521,"startTime":"0","endTime":"0","summary":"   * NRX Pharmaceuticals Inc    预计将于5月14日公布截至2024年3月31日的财报。*    * LSEG分析师对NRX Pharmaceuticals Inc的平均预期是每股亏损55美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为 2 个 \"强烈买入 \"或 \"买入\"，没有 \"持有\"，也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 NRX Pharmaceuticals Inc 的 12 个月目标价中位数为 35.00 美元，高于其上一次收盘价 2.93 美元。5月10日 - 本摘要于北京时间 5 月 10 日 20:38 机器生成。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP"],"gpt_icon":0},{"id":"2422621624","title":"NRX Pharmaceuticals Inc    预计每股亏损 7 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2422621624","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422621624?lang=zh_cn&edition=full","pubTime":"2024-03-27 04:24","pubTimestamp":1711484663,"startTime":"0","endTime":"0","summary":"   * NRX Pharmaceuticals Inc    预计将于3月28日公布截至2023年12月31日的财报。*    * LSEG的分析师平均预计NRX Pharmaceuticals Inc每股亏损7美分。* 华尔街对 NRX Pharmaceuticals Inc 的 12 个月目标价中位数为 2.00 美元，高于上一次 0.53 美元的收盘价。3月26日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nrxpharma.com","stockEarnings":[{"period":"1week","weight":0.2023},{"period":"1month","weight":-0.144},{"period":"3month","weight":-0.4734},{"period":"6month","weight":-0.5273},{"period":"1year","weight":-0.3882},{"period":"ytd","weight":-0.5478}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NRX Pharmaceuticals, Inc.是于2015年5月20日依照特拉华州法律成立的公司，是一家临床阶段的小分子制药公司，开发用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.17342},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.0504},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.073314},{"month":4,"riseRate":0,"avgChangeRate":-0.311577},{"month":5,"riseRate":0.666667,"avgChangeRate":0.013246},{"month":6,"riseRate":0.25,"avgChangeRate":-0.267026},{"month":7,"riseRate":0.5,"avgChangeRate":0.093346},{"month":8,"riseRate":0.25,"avgChangeRate":-0.120326},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.130012},{"month":10,"riseRate":1,"avgChangeRate":0.145789},{"month":11,"riseRate":0.666667,"avgChangeRate":0.165222},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.058796}],"exchange":"NASDAQ","name":"NRX Pharmaceuticals Inc.","nameEN":"NRX Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NRX Pharmaceuticals Inc.(NRXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NRX Pharmaceuticals Inc.(NRXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NRX Pharmaceuticals Inc.,NRXP,NRX Pharmaceuticals Inc.股票,NRX Pharmaceuticals Inc.股票老虎,NRX Pharmaceuticals Inc.股票老虎国际,NRX Pharmaceuticals Inc.行情,NRX Pharmaceuticals Inc.股票行情,NRX Pharmaceuticals Inc.股价,NRX Pharmaceuticals Inc.股市,NRX Pharmaceuticals Inc.股票价格,NRX Pharmaceuticals Inc.股票交易,NRX Pharmaceuticals Inc.股票购买,NRX Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NRX Pharmaceuticals Inc.(NRXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NRX Pharmaceuticals Inc.(NRXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}